Chief Scientific Officer & CEO Adi Mor, PhD and Chief Medical Officer Frankel, along with Dr. Bowlus, UC Davis Health, discuss primary sclerosing cholangitis (PSC) on a conference call to be held on April 10 at 10 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMMB:
- Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
- Chemomab Therapeutics awarded European patent for CM-101
- Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
- Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results and Provides a Corporate Update
- CMMB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Questions or Comments about the article? Write to editor@tipranks.com